New Mexico Health Reporter: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on New Mexico Health Reporter.

Press releases published on June 29, 2026

Jun. 29, 2026

FDA Approves Arcutis’ ZORYVE® (roflumilast) Cream 0.3% for the Treatment of Plaque Psoriasis in Children as Young as Age 2

Indeterminate GlobeNewswire

Jun. 29, 2026

Twentyeight Health partners with Clue to expand access to affordable birth control nationwide

Indeterminate GlobeNewswire

Jun. 29, 2026

PetVivo Reports Financial and Operational Results for Fiscal 2026

Indeterminate GlobeNewswire

Jun. 29, 2026

Zoumalan, MD FACS Inc. Announces Its Natural Looking Blepharoplasty® Approach as Demand Grows for Natural Eyelid Surgery Results

Indeterminate GlobeNewswire

Jun. 29, 2026

FISHER HOUSE FOUNDATION RECEIVES “FOUR STARS” FOR 22nd YEAR FROM CHARITY NAVIGATOR, A+ FROM CHARITY WATCH

Indeterminate GlobeNewswire

Jun. 29, 2026

Publication relating to transparency notifications

Indeterminate GlobeNewswire

Jun. 29, 2026

Silo Pharma Advances SPC-15 PTSD Therapeutic with Drug-Device Robustness Study Ahead of Planned FDA Type C Meeting Request

Indeterminate GlobeNewswire

Jun. 29, 2026

Genmab Announces Positive Phase 3 Results for Epcoritamab Plus Lenalidomide in Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma, Demonstrating Statistically Significant Improvement in Progression-Free Survival

Indeterminate GlobeNewswire

Jun. 29, 2026

Résultats positifs de la partie 2 de l’essai de maintenance ABTECT démontrant un bénéfice clinique significatif chez des patients atteints de RCH réfractaire et renforçant les données de sécurité

Indeterminate GlobeNewswire

Jun. 29, 2026

Lakefront ontvangt transparantieverklaring van Madison Avenue Partners

Indeterminate GlobeNewswire

Jun. 29, 2026

Nuvectis Pharma Announces Proposed Public Offering of Common Stock

Indeterminate GlobeNewswire

Jun. 29, 2026

DBV Technologies Provides BLA Submission Update for the VIASKIN® Peanut Patch in Children Aged 4 through 7 Years; Working Collaboratively with FDA to Optimize Review Process in Preparation for Filing

Indeterminate GlobeNewswire

Jun. 29, 2026

DBV Technologies fait le point sur le dépôt du dossier BLA pour le patch VIASKIN® Peanut chez les enfants âgés de 4 à 7 ans; la Société travaille en collaboration avec la FDA afin d'optimiser le processus d'examen en vue du dépôt du dossier

Indeterminate GlobeNewswire

Jun. 29, 2026

JellyFil Documents 2026 Supplement Facts Panel Composition, 8-Ingredient Proprietary Blend, and Manufacturing Disclosure for Its Gummy Dietary Supplement

Indeterminate GlobeNewswire

Jun. 29, 2026

Neutra Corp’s Subsidiary Neutra Life Sciences Executes New Women’s Health Joint Venture and Expands Trial Portfolio

Indeterminate GlobeNewswire

Jun. 29, 2026

Canada's first "talking statue" debuts at Banting House this summer—hear from Sir Frederick Banting himself

Indeterminate GlobeNewswire

Jun. 29, 2026

BrewDog and Tilray Beer Add Canada to The World's Biggest Bar Tab as Canada Advances to the Next Round

Indeterminate GlobeNewswire

Jun. 29, 2026

EmblemHealth Sees 50% Increase in Member Adoption and Engagement Following Debut of Redesigned Mobile App

Indeterminate GlobeNewswire

Jun. 29, 2026

Zealand Pharma - Transactions related to share buy-back program (week 26, 2026)

Indeterminate GlobeNewswire

Jun. 29, 2026

American Kidney Fund Launches New Kidney Transplant Resources to Help Patients Navigate Evaluation, Surgery and Recovery

Indeterminate GlobeNewswire